Broad spectrum of microbial antigens

Broad spectrum of microbial antigens refers to a diverse collection of molecular structures, including proteins, polysaccharides, and lipids, derived from a wide range of pathogenic microorganisms such as bacteria, viruses, and fungi (Janeway's Immunobiology, 9th edition). These antigens are recognized by the host immune system as foreign, primarily through Pathogen-Associated Molecular Patterns (PAMPs), which trigger innate and adaptive immune responses (Nature Reviews Immunology). In the context of pharmacology, this term does not represent a single molecular target but rather a broad category of targets for interventions like polyvalent vaccines and intravenous immunoglobulin (IVIG) (StatPearls). These therapies are designed to provide broad-spectrum protection by neutralizing various pathogens and their toxins or by enhancing opsonization and phagocytosis (NIH - National Institute of Allergy and Infectious Diseases). While this approach is vital for treating or preventing multi-pathogen infections, it presents challenges such as the risk of hypersensitivity, serum sickness, or antibody-dependent enhancement (PubMed - PMC4215217). The complexity of these antigens requires careful selection to ensure cross-reactivity and efficacy across different microbial strains. Consequently, this target group is central to the development of universal vaccines and emergency passive immunotherapies.

Other names

Microbial antigensPathogen-associated molecular patternsPAMPsPolyvalent antigensMulti-valent antigens

Drugs targeting a broad spectrum of microbial antigens typically work by neutralizing pathogens, blocking their entry into host cells, or opsonizing them for clearance by phagocytes (StatPearls).